Isoflurane-enhanced recovery of canine stunned myocardium: Role for protein kinase C?

Anesthesiology

Volumn 91, Issue 3, 1999, Pages 713-722

  Toller, Wolfgang G ^b   Montgomery, Matthew W ^b   Pagel, Paul S ^b   Hettrick, Douglas A ^b   Warltier, David C ^b   Kersten, Judy R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

Bisindolylmaleimide; Myocardial ischemia; Volatile anesthetics

Indexed keywords

BISINDOLYLMALEIMIDE; ISOFLURANE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; FEMALE; HEART LEFT VENTRICLE DP-DT; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILITY; HEART PROTECTION; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; STUNNED HEART MUSCLE;

EID: 0032842470     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199909000-00024     Document Type: Article

References (34)

1. Braunwald E, Kloner RA: The stunned myocardium: Prolonged, postischemic ventricular dysfunction. Circulation 1982; 66:1146-9
2. Bolli R: Mechanism of myocardial 'stunning.' Circulation 1990; 82:723-38
3. Warltier DC, al-Wathiqui MH, Kampine JP, Schmeling WT: Recovery of contractile function of stunned myocardium in chronically instrumented dogs is enhanced by halothane or isoflurane. ANESTHESIOLOGY 1988; 69:552-65
4. ATP) channels. ANESTHESIOLOGY 1996; 85:794-807
5. Oguchi T, Kashimoto S, Yamaguchi T, Nakamura T, Kumazawa T: Comparative effects of halothane, enflurane, isoflurane and sevoflurane on function and metabolism in the ischaemic rat heart. Br J Anaesth 1995; 74:569-75
6. Kanaya N, Fujita S: The effects of isoflurane on regional myocardial contractility and metabolism in 'stunned' myocardium in acutely instrumented dogs. Anesth Analg 1994; 79:447-54
7. Kanaya N, Kobayashi I, Nakayama M, Fujita S, Namiki A: ATP sparing effect of isoflurane during ischaemia and reperfusion of the canine heart. Br J Anaesth 1995; 74:563-8
8. ATP channel antagonist, attenuates the cardioprotective effects of isoflurane in stunned myocardium. Anesth Analg 1996; 83: 27-33
9. Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC: Role of adenosine in isoflurane-induced cardioprotection. ANESTHESIOLOGY 1997; 86:1128-39
10. ATP channels: Reduction of myocardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87:361-70
11. + channels by protein kinase C. Circ Res 1998; 83:110-4
12. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 1995; 77:1030-5
13. Light PE, Allen BG, Walsh MP, French RJ: Regulation of adenosine triphosphate-sensitive potassium channels from rabbit ventricular myocytes by protein kinase C and type 2A protein phosphatase. Biochemistry 1995; 34:7252-7
14. Light PE, Sabir AA, Allen BG, Walsh MP, French RJ: Protein kinase C-induced changes in the stoichiometry of ATP binding activate cardiac ATP-sensitive K+ channels. A possible mechanistic link to ischemic preconditioning. Circ Res 1996; 79:399-406
15. Ytrehus K, Liu Y, Downey JM: Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994; 266:H1145-52
16. Kitakaze M, Node K, Minamino T, Komamura K, Funaya H, Shinozaki Y, Chujo M, Mori H, Inoue M, Hori M, Kamada T: Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase. Circulation 1996; 93:781-91
17. Cope DK, Impastato WK, Cohen MV, Downey JM: Volatile anesthetics protect the ischemic rabbit myocardium from infarction. ANESTHESIOLOGY 1997; 86:699-709
18. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F: The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 1991; 266:15771-81
19. Mitchell M.B., Meng X, Ao L, Brown JM, Harken AH, Banerjee A: Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995; 76:73-81
20. Steinberg SF, Goldberg M, Rybin VO: Protein kinase C isoform diversity in the heart. J Mol Cell Cardiol 1995; 27:141-53
21. Simkhovich BZ, Przyklenk K, Kloner RA: Role of protein kinase C as a cellular mediator of ischemic preconditioning: A critical review. Cardiovasc Res 1998; 40:9-22
22. Erdbrugger W, Keffel J, Knocks M, Otto T, Philipp T, Michel MC: Protein kinase C isoenzymes in rat and human cardiovascular tissues. Br J Pharmacol 1997; 120:177-86
23. Tosaki A, Maulik N, Engelman DT, Engelman RM, Das DK: The role of protein kinase in C ischemic/reperfused preconditioned isolated rat hearts. J Cardiovasc Pharmacol 1996; 28:723-31
24. Vogt AM, Htun P, Arras M, Podzuweit T, Schaper W: Intramyocardial infusion of tool drugs for the study of molecular mechanisms in ischemic preconditioning. Basic Res Cardiol 1996; 91:389-400
25. Lasley RD, Noble MA, Mentzer RM Jr: Effects of protein kinase C inhibitors in in situ and isolated ischemic rabbit myocardium. J Mol Cell Cardiol 1997; 29:3345-56
26. Toda H, Su JY: Mechanisms of isoflurane-increased submaximum Ca2+-activated force in rabbit skinned femoral arterial strips. ANESTHESIOLOGY 1998; 89:731-40
27. Ping P, Zhang J, Qiu Y, Tang XL, Manchikalapudi S, Cao X, Bolli R: Ischemic preconditioning induces selective translocation of protein kinase C isoforms epsilon and eta in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 1997; 81:404-14
28. Gray MO, Karliner JS, Mochly-Rosen D: A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 1997; 272:30945-51
29. Miura T, Miura T, Kawamura S, Goto M, Sakamoto J, Tsuchida A, Matsuzaki M, Shimamoto K: Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes. Cardiovasc Res 1998; 37:700-9
30. Sandhu R, Diaz RJ, Mao GD, Wilson GJ: Ischemic preconditioning: Differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia. Circulation 1997; 96:984-95
31. Kersten JR, Gross GJ, Pagel PS, Warltier DC: Activation of adenosine triphosphate-regulated potassium channels: Mediation of cellular and organ protection. ANESTHESIOLOGY 1998; 88:495-513
32. Ismaeil M, Tkachenko I, Hickey R, Cason BA: Colchicine inhibits isoflurane-induced myocardial preconditioning (abstract). ANESTHESIOLOGY 1998; 89:A595
33. Baines CP, Wang L, Cohen MV, Downey JM: Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J Mol Cell Cardiol 1998; 30:383-92
34. Vahlhaus C, Schulz R, Post H, Rose J, Heusch G: Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol 1998; 30:197-209